Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Knatterud

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Clinical Cardiology|August 1, 1996
Factors limiting the enrollment of women in a randomized coronary artery disease trial. The Asymptomatic Cardiac Ischemia Pilot Study (ACIP) InvestigatorsR M Steingart, S Forman, M Coglianese, et al.
Circulation|February 1, 1992
One-year results of the Thrombolysis in Myocardial Infarction investigation (TIMI) Phase II TrialD O Williams, E Braunwald, G Knatterud, et al.
Circulation|July 1, 1987
Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital dischargeJ H Chesebro, G Knatterud, R Roberts, et al.
The American Journal of Cardiology|January 1, 1992
Assessment of global and regional left ventricular performance at rest and during exercise after thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) II StudyB L Zaret, F J Wackers, M L Terrin, et al.
Journal of the American College of Cardiology|January 1, 1988
Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinaseA K Rao, C Pratt, A Berke, et al.
Journal of the American College of Cardiology|November 1, 1985
High dose intravenous streptokinase for acute myocardial infarction: preliminary results of a multicenter trialL D Hillis, J Borer, E Braunwald, et al.
Circulation|February 1, 1986
Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI thrombolysis in myocardial infarction trialD O Williams, J Borer, E Braunwald, et al.
Lancet (London, England)|December 18, 1993
Individual risk assessment for intracranial haemorrhage during thrombolytic therapyM L Simoons, A P Maggioni, G Knatterud, et al.
Journal of the American College of Cardiology|July 1, 1997
Outcome and profile of women and men presenting with acute coronary syndromes: a report from TIMI IIIB. TIMI Investigators. Thrombolysis in Myocardial InfarctionJ S Hochman, C H McCabe, P H Stone, et al.
Journal of Clinical Apheresis|January 1, 1991
Plasmapheresis and subsequent pulse cyclophosphamide versus pulse cyclophosphamide alone in severe lupus: design of the LPSG trial. Lupus Plasmapheresis Study Group (LPSG)W F Clark, P C Dau, H H Euler, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Clinical Cardiology|August 1, 1996
Factors limiting the enrollment of women in a randomized coronary artery disease trial. The Asymptomatic Cardiac Ischemia Pilot Study (ACIP) InvestigatorsR M Steingart, S Forman, M Coglianese, et al.
Circulation|February 1, 1992
One-year results of the Thrombolysis in Myocardial Infarction investigation (TIMI) Phase II TrialD O Williams, E Braunwald, G Knatterud, et al.
Circulation|July 1, 1987
Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital dischargeJ H Chesebro, G Knatterud, R Roberts, et al.
The American Journal of Cardiology|January 1, 1992
Assessment of global and regional left ventricular performance at rest and during exercise after thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) II StudyB L Zaret, F J Wackers, M L Terrin, et al.
Journal of the American College of Cardiology|January 1, 1988
Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinaseA K Rao, C Pratt, A Berke, et al.
Journal of the American College of Cardiology|November 1, 1985
High dose intravenous streptokinase for acute myocardial infarction: preliminary results of a multicenter trialL D Hillis, J Borer, E Braunwald, et al.
Circulation|February 1, 1986
Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI thrombolysis in myocardial infarction trialD O Williams, J Borer, E Braunwald, et al.
Lancet (London, England)|December 18, 1993
Individual risk assessment for intracranial haemorrhage during thrombolytic therapyM L Simoons, A P Maggioni, G Knatterud, et al.
Journal of the American College of Cardiology|July 1, 1997
Outcome and profile of women and men presenting with acute coronary syndromes: a report from TIMI IIIB. TIMI Investigators. Thrombolysis in Myocardial InfarctionJ S Hochman, C H McCabe, P H Stone, et al.
Journal of Clinical Apheresis|January 1, 1991
Plasmapheresis and subsequent pulse cyclophosphamide versus pulse cyclophosphamide alone in severe lupus: design of the LPSG trial. Lupus Plasmapheresis Study Group (LPSG)W F Clark, P C Dau, H H Euler, et al.
Pageof 3